Ophthalmic Associates A Professional Corporation - Medicare in Anchorage, AK

Ophthalmic Associates A Professional Corporation is a medicare enrolled "Ophthalmology" provider in Anchorage, Alaska. Their current practice location is 542 W 2nd Ave, Anchorage, Alaska. You can reach out to their office (for appointments etc.) via phone at (907) 276-1617.

Ophthalmic Associates A Professional Corporation is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Ophthalmic Associates A Professional Corporation is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1255325692.

Contact Information

Ophthalmic Associates A Professional Corporation
542 W 2nd Ave,
Anchorage, AK 99501-2208
(907) 276-1617
(907) 264-2664



Healthcare Provider's Profile

Full NameOphthalmic Associates A Professional Corporation
TypeFacility
SpecialityOphthalmology
Location542 W 2nd Ave, Anchorage, Alaska
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1255325692
  • Provider Enumeration Date: 08/31/2005
  • Last Update Date: 04/18/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 4183515596
  • Enrollment ID: O20040324000384

Medical Identifiers

Medical identifiers for Ophthalmic Associates A Professional Corporation such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1255325692NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Secondary
207W00000XOphthalmology (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Ophthalmic Associates A Professional Corporation acts as a billing entity for following providers:
Provider NameElizabeth N Morgan
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1811980311
PECOS PAC ID: 2062404999
Enrollment ID: I20040331001589

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Provider NameGriffith C Steiner
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1700879269
PECOS PAC ID: 4183713944
Enrollment ID: I20101022001057

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Provider NameCarl E Rosen
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1306839873
PECOS PAC ID: 7911096771
Enrollment ID: I20101209000433

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Provider NameRobert W Arnold
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1942293428
PECOS PAC ID: 5193814952
Enrollment ID: I20101209000675

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Provider NameNathan Frank
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1588812390
PECOS PAC ID: 4688726961
Enrollment ID: I20131231001000

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Provider NameKelly Lorenz
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1508068636
PECOS PAC ID: 5496891608
Enrollment ID: I20150729009082

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Provider NameEileen M Myers
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1447546197
PECOS PAC ID: 8426297326
Enrollment ID: I20200213003093

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Provider NameLaura E Langford
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1851821615
PECOS PAC ID: 9739441262
Enrollment ID: I20201007001800

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Provider NameKristi Y Wu
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1700382827
PECOS PAC ID: 4385970870
Enrollment ID: I20230721001654

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Provider NameJulia Shatten
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1205330784
PECOS PAC ID: 0042574675
Enrollment ID: I20230802002373

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ophthalmic Associates A Professional Corporation is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Ophthalmic Associates A Professional Corporation
542 W 2nd Ave,
Anchorage, AK 99501-2208

Ph: (907) 276-1617
Ophthalmic Associates A Professional Corporation
542 W 2nd Ave,
Anchorage, AK 99501-2208

Ph: (907) 276-1617

News Archive

International community must address MSM population in order to end AIDS epidemic

"Over the 30 years of the AIDS epidemic, the disease has had a profound impact on every country in the world," and "in each country, that impact is experienced a different way," Vivek Anand, CEO of the Humsafar Trust, and Kenneth Mayer, medical research director of Fenway Health and co-director of the Fenway Institute, write in this post in Huffington Post's "Gay Voices" blog.

Guardian examines African environmental outlook report

The Guardian highlights the African Environment Outlook-3, a report released last month by the United Nations Environment Programme that examines "[t]he multifaceted connection between environmental and human health."

Range of biopharma solutions from Malvern Instruments extended by distribution agreement with Affinity Biosensors

Materials characterization company Malvern Panalytical. (Malvern Panalytical, UK) has signed an exclusive distribution agreement with Affinity Biosensors LLC (Santa Barbara, CA, USA) which will extend the range of solutions that Malvern Panalytical offers to the biopharmaceutical sector.

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

Read more News

› Verified 8 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.